Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTRACTION: Tirofiban After Mechanical Thrombectomy in Acute Ischemic Stroke
NCT06265051Phase 3Completed
- Start
- Apr 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Tirofiban group with Placebo group (2 arms). Primary endpoints: Proportion of patients functionally independent (mRS score 0 to 2) at 90 days and Symptomatic intracranial hemorrhage at 48 hours. Started Apr 2024; status: completed.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06265051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06265051.